nicotine dependency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients who succeed in smoking cessation at the time of the fifth visit (Definition of success in smoking cessation: expired carbon monoxide concentration of less than 7 ppm and the patient affirmation of no smoking for one week (2)Patients within one month from the fifth visit (3)Patients with weight gain more than 1kg from the first visit to the fifth visit to smoking cessation clinic (4)Pacients who gave informed written consent
Exclusion criteria
Exclusion criteria: (1)Patients who receive nourishment instruction regularly (2)Patients in an unfavorable state for nourishment instruction enforcement (e.g., shock state, serious infectious disease,acute phase of cerebral infarction or myocardial infarction, terminal stage of cancer, remarkabe gastrointestinal weakness) (3)Pregnancy or breastfeeding patients (4)Patients who take steroid regularly (5)Patients with uncontrolled diabetes mellitus (with HbA1c level more than 10.0%) (5)Patients who are judged to be unsuitable to paticipate in this clinical trial by a doctor (e,g,. patients with advanced dementia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular risk marker: AT-LDL, SAA-LDL, high sensitivity CRP, LOX index, adiponectin | — |
Secondary
| Measure | Time frame |
|---|---|
| Glucose and lipid metabolism (HbA1c, LDL-C, HDL-C, non-HDL-C, leptin), body weight (BMI) and waist circumference, continuous abstinence rate from smoking | — |
Countries
Japan
Contacts
National Hospital Organization Kyoto Medical Center Division of Translational Research